Xeris Biopharma Holdings (XERS) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to -$12.2 million.
- Xeris Biopharma Holdings' Other Gross PP&E Adjustments rose 5.58% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.6 million, marking a year-over-year increase of 3.17%. This contributed to the annual value of -$19.5 million for FY2024, which is 2.98% down from last year.
- Xeris Biopharma Holdings' Other Gross PP&E Adjustments amounted to -$12.2 million in Q3 2025, which was up 18.96% from -$15.0 million recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Other Gross PP&E Adjustments ranged from a high of $11.0 million in Q2 2022 and a low of -$19.5 million during Q4 2024.
- For the 3-year period, Xeris Biopharma Holdings' Other Gross PP&E Adjustments averaged around -$14.7 million, with its median value being -$15.8 million (2024).
- Within the past 5 years, the most significant YoY rise in Xeris Biopharma Holdings' Other Gross PP&E Adjustments was 9.39% (2024), while the steepest drop was 5,426.05% (2024).
- Quarterly analysis of 5 years shows Xeris Biopharma Holdings' Other Gross PP&E Adjustments stood at $7.6 million in 2021, then crashed by 82.28% to $1.3 million in 2022, then crashed by 1,509.90% to -$18.9 million in 2023, then dropped by 2.98% to -$19.5 million in 2024, then rose by 5.58% to -$12.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$12.2 million in Q3 2025, compared to -$15.0 million in Q2 2025 and -$17.8 million in Q1 2025.